University Health Network: Princess Margaret Cancer Centre
University Health Network: Princess Margaret Cancer Centre
Toronto, Ontario, Canada1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Kadcyla And Neratinib for Interception of HER2+ Breast Cancer With Molecular Residual Disease | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 2 | 2025-01-31 | NCT05388149 |